Concourse Financial Group Securities, Inc. Harrow Health, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$33.39 - $57.5 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$20.85 - $46.47 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$10.0 - $21.64 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$9.3 - $13.23 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$8.1 - $16.36 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$14.03 - $22.08 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$14.03 - $22.08 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$17.37 - $28.08 $0 - $0
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$10.28 - $14.78 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$6.57 - $24.88 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.75 - $7.74 $0 - $0
Q1 2022 May 09, 2022	BUY	$6.77 - $8.66 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$8.5 - $12.0 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$6.99 - $10.6 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$6.68 - $11.07 $0 - $0
Q1 2021 May 13, 2021	BUY	$6.26 - $11.03 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$4.76 - $6.93 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.71 - $7.36 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.61 - $6.47 $0 - $0
Q1 2020 May 13, 2020	BUY	$3.5 - $7.31 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.89 - $8.0 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$4.2 - $8.7 $0 - $0
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $0 - $0

Others Institutions Holding HROW

# of Institutions

184

Shares Held

21.1M

Call Options Held

679K

Put Options Held

1.27M

Opaleye Management Inc. Boston, MA

3.99M
Shares

$122 Million
26.33% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$65.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$57.1 Million
0.0% of portfolio
Private Capital Management, LLC Naples, FL

1.69M
Shares

$51.7 Million
6.85% of portfolio
Braidwell LP Stamford, CT

907K
Shares

$27.6 Million
1.7% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $825M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account